Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study
2023; Springer Science+Business Media; Volume: 26; Issue: 3 Linguagem: Inglês
10.1007/s12094-023-03295-2
ISSN1699-3055
AutoresJesús García-Donás, Guillermo de Velasco, Rodrigo Madurga, Jesús Chamorro, Diana Isabel Rosero, Olatz Etxániz, Jose Luis Pérez‐Gracia, Álvaro Pinto, Diego Cacho, Maria Luiza Ferreira De Barba, Pablo Borrega, Martín Lázaro, Laura Rodríguez, L. Villalobos, Lourdes García, Andrés Cuellar, María Pilar Solís-Hernández, Amalia Castelli González, Cristina Pernaut, Juan Francisco Rodríguez-Moreno,
Tópico(s)Healthcare cost, quality, practices
Referência(s)